Drug Trial Radar · NCT03602261
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Last checked: Nov 19, 2026Latest source record: Apr 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
44
Actual
Start
Jul 9, 2018
Primary completion
Feb 24, 2021
Study completion Feb 24, 2021
Sponsor
- Lead sponsor
- OPKO Health, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 26, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI
Conditions
- Secondary Hyperparathyroidism Due to Renal Causes
- Chronic Kidney Diseases
- Vitamin D Deficiency
- Stage 5 Chronic Kidney Disease
Interventions
Calcifediol Oral CapsuleDrug
Capsule, weekly
Placebo oral capsuleDrug
Capsule, weekly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Response During Efficacy Assessment PeriodTime frame: 26 weeks
- Total 25-hydroxyvitamin D Response Analysis During Efficacy PeriodTime frame: 26 weeks
- Number of Participants With Intact Parathyroid Hormone (iPTH) Response During Efficacy Assessment PeriodTime frame: 26 weeks
- Pharmacokinetic (PK) Profile (Cmax) of Serum CalcifediolTime frame: 0, 4, 8, 12, 16, 20, 24, 30, 36, 42 and 48 hours post-dose (single and repeat dose)
- Pharmacokinetic (PK) Profile (Tmax) of Serum CalcifediolTime frame: 0, 4, 8, 12, 16, 20, 24, 30, 36, 42 and 48 hours post-dose (single and repeat dose)
- Pharmacokinetic (PK) Profile (AUC0-t) of Serum CalcifediolTime frame: 0, 4, 8, 12, 16, 20, 24, 30, 36, 42 and 48 hours post-dose (single and repeat dose)
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
AKDHC Medical Research Services
Peoria, Arizona
AKDHC Medical Research Services
Phoenix, Arizona
AKDHC Medical Research Services
Phoenix, Arizona
AKDHC Medical Research Services
Phoenix, Arizona
WCCT Global, Inc.
Cypress, California
Hacienda Dialysis Center
Hacienda Heights, California
California Institute of Renal Research CKD/Dialysis & Transplant Division
La Mesa, California
Long Beach Quest Dialysis Center
Long Beach, California
Ontario Dialysis Center
Ontario, California
North America Research Institute, Inc.
San Dimas, California
Laurel Canyon Dialysis, LLC
Sun Valley, California
University of Colorado Denver Anschutz Medical Campus
Aurora, Colorado
Research by Design, LLC
Chicago, Illinois
Northshore University Health
Evanston, Illinois
Renal and Transplant Associates of New England
Springfield, Massachusetts
Southwest MS Nephrology
McComb, Mississippi
Southwest Houston Research LTD
Houston, Texas
Kidney & Hypertension Specialists
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.